Stock Analiz

IDXX vs LNTH stock comparison

IDEXX Laboratories vs. Lantheus · data as of November 13, 2026

IDEXX Laboratories (IDXX) has a market value of about $55.5B, Lantheus (LNTH) about $6.6B. Over their latest twelve months IDEXX Laboratories had revenue of $4.7B and Lantheus $1.6B.

On our five checks IDEXX Laboratories scores higher: 3.4 out of 5 (good) against 2.6 (average).

By area, the stronger company is Lantheus on value; IDEXX Laboratories on future growth; IDEXX Laboratories on track record; IDEXX Laboratories on shareholder returns.

Lantheus is cheaper on earnings (P/E 25.1 vs. 47.5).

IDEXX Laboratories leads on 10 of the compared lines and Lantheus on 11.

Side by side

IDXXLNTH
Size and price
Market cap$55.5B$6.6B
Share price$704.23$101.59
Score
Overall score (of 5)3.42.6
Value01
Future growth43
Track record52
Financial health55
Shareholder returns32
Valuation
P/E (TTM)47.525.1
Forward P/E44.816.0
Price / free cash flow42.616.9
Price / sales11.94.3
EV / EBITDA33.517.2
PEG3.32—
DCF value vs. price−63%−35%
Business
Revenue$4.7B$1.6B
Net income$1.2B$270M
Free cash flow$1.3B$393M
Net margin25.4%17.3%
Gross margin (5-yr avg.)60.2%57.3%
ROIC (5-yr avg.)44.1%9.4%
Growth
Revenue growth (1 yr)10.4%0.5%
Revenue growth (5 yrs, per year)9.7%35.4%
EPS growth (5 yrs, per year)14.3%—
Balance sheet and payouts
Net cash (cash minus debt)-$301M$59M
Dividend yieldNoneNone
Shareholder yield2.2%4.5%
Analysts
Upside to average target+2%+4%
Consensus ratingBuyHold

Highlighted = the better figure on that line. Revenue, net income and free cash flow: IDXX TTM to September 30, 2026, LNTH TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, IDEXX Laboratories or Lantheus?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) IDEXX Laboratories scores 3.4 out of 5 and Lantheus 2.6; the table shows where each one is stronger.

Is IDEXX Laboratories cheaper than Lantheus?

On trailing earnings, Lantheus trades at a P/E of 25.1 and IDEXX Laboratories at 47.5, so Lantheus is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, IDEXX Laboratories or Lantheus?

Over five years Lantheus grew revenue about 35.4% a year and IDEXX Laboratories about 9.7% a year.

Full IDEXX Laboratories analysis → Full Lantheus analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.